Literature DB >> 9676626

Chemokine macrophage inflammatory protein-1alpha mRNA expression in lung biopsy specimens of primary pulmonary hypertension.

M Fartoukh1, D Emilie, C Le Gall, G Monti, G Simonneau, M Humbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9676626     DOI： 10.1378/chest.114.1_supplement.50s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  17 in total

1.  Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.

Authors:  Meiqian Weng; Michael J Raher; Patricio Leyton; Terry P Combs; Philipp E Scherer; Kenneth D Bloch; Benjamin D Medoff
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-12       Impact factor: 6.914

2.  Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension.

Authors:  Michael G Risbano; Christina A Meadows; Christopher D Coldren; Tiffany J Jenkins; Michael G Edwards; David Collier; Wendy Huber; Douglas G Mack; Andrew P Fontenot; Mark W Geraci; Todd M Bull
Journal:  Clin Transl Sci       Date:  2010-10       Impact factor: 4.689

3.  Neutrophil/Lymphocyte Ratio Can Predict Postoperative Mortality in Patients with Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Mehmed Yanartas; Mehmet Emin Kalkan; Akin Arslan; Serpil Gezer Tas; Cengiz Koksal; Nural Bekiroglu; Bedrettin Yildizeli
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-03-09       Impact factor: 1.520

4.  Bone morphogenetic protein signaling in vascular disease: anti-inflammatory action through myocardin-related transcription factor A.

Authors:  Dahai Wang; Jamunabai Prakash; Peter Nguyen; Brandi N Davis-Dusenbery; Nicholas S Hill; Matthew D Layne; Akiko Hata; Giorgio Lagna
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

5.  Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II.

Authors:  Victoria J Burton; Alan M Holmes; Loredana I Ciuclan; Alexander Robinson; Jan S Roger; Gabor Jarai; Andrew C Pearce; David C Budd
Journal:  Blood       Date:  2011-09-07       Impact factor: 22.113

6.  Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension.

Authors:  M Weng; D M Baron; K D Bloch; A D Luster; J J Lee; B D Medoff
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-09       Impact factor: 5.464

7.  Impairment of monocyte-derived dendritic cells in idiopathic pulmonary arterial hypertension.

Authors:  Weiyan Wang; Hui Yan; Weiguo Zhu; Yu Cui; Junzhu Chen; Xingxiang Wang; Shan Li; Jianhua Zhu
Journal:  J Clin Immunol       Date:  2009-08-20       Impact factor: 8.317

Review 8.  [Thromboembolism and pulmonary hypertension].

Authors:  D Drömann
Journal:  Internist (Berl)       Date:  2009-09       Impact factor: 0.743

Review 9.  Immune and inflammatory mechanisms in pulmonary arterial hypertension.

Authors:  Hala El Chami; Paul M Hassoun
Journal:  Prog Cardiovasc Dis       Date:  2012 Sep-Oct       Impact factor: 8.194

10.  HIV protease inhibitors in pulmonary hypertension: rationale and design of a pilot trial in idiopathic pulmonary arterial hypertension.

Authors:  Ying Li; Xiao-Hui Li; Zai-Xin Yu; Jing-Jing Cai; Timothy R Billiar; Alex F Chen; Ben Lv; Zi-Ying Chen; Zhi-Jun Huang; Guo-Ping Yang; Jie Song; Bin Liu; Hong Yuan
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.